Binosto Oral Effervescent Tablet, Weekly 70Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

Binosto: Oral effervescent tablet, weekly (70mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png
Binosto 70mg Effervescent Tab

What is this Medicine?

ALENDRONATE (a LEN droe nate) slows calcium loss from bones. It helps to make healthy bone and to slow bone loss in people with osteoporosis.

CVS Pharmacy Patient Statistics for Binosto: Oral effervescent tablet, weekly(70mg)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information

Binosto 70mg Effervescent Tablet

NDC: 001780101
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Osteoporosis

Storage Information
Store in original package until time of use
Protect from moisture
Store between 68 to 77 degrees F, excursions permitted 59 to 86 degrees F
Binosto 70mg Effervescent Tablet

Reported Side Effects for Binosto 70mg Effervescent Tablet

Muscle Cramps Incidence:
<1.1%*
Severity: MILD
Onset: DELAYED
Melena Incidence:
<1.3%*
Severity: MODERATE
Onset: DELAYED
Stomach Ulcer Incidence:
<1.1%*
Severity: SEVERE
Onset: DELAYED
Upset Stomach Incidence:
<3.6%*
Severity: MILD
Onset: EARLY
Constipation Incidence:
<3.1%*
Severity: MODERATE
Onset: DELAYED
Loose Stools Incidence:
<3.1%*
Severity: MILD
Onset: EARLY
Gas Incidence:
<4.1%*
Severity: MILD
Onset: EARLY
Headache Incidence:
<2.6%*
Severity: MILD
Onset: EARLY
Throat Ulcers Incidence:
0.1-1.5%*
Severity: SEVERE
Onset: DELAYED
Metallic Taste Incidence:
0.1-0.5%*
Severity: MILD
Onset: EARLY
Difficulty Swallowing Incidence:
0.1-1.0%*
Severity: MODERATE
Onset: DELAYED
Vomiting Incidence:
0.2-1.0%*
Severity: MILD
Onset: EARLY
Inflamed Stomach Incidence:
0.2-1.1%*
Severity: MODERATE
Onset: DELAYED
Muscle And/Or Bone Pain Incidence:
0.4-6.0%*
Severity: MILD
Onset: EARLY
Heartburn Incidence:
0.7-2.8%*
Severity: MILD
Onset: DELAYED
Stomach Pain Incidence:
0.9-6.6%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
1.1-3.6%*
Severity: MILD
Onset: EARLY
Low Phosphate Level Incidence:
10.0%*
Severity: MODERATE
Onset: DELAYED
Low Calcium Levels Incidence:
18.0%*
Severity: MODERATE
Onset: DELAYED
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Daily Life Interactions for Binosto 70mg Effervescent Tablet

Elements of your daily lifestyle may have an effect on the medications you are taking. Drug interactions can result in unwanted side effects, reduce the effectiveness of your medicine or possibly increase the action of a particular medicine.

Major Lifestyle Interaction
Food and Binosto 70mg Effervescent Tablet(Alendronate Sodium)
Food and Alendronate Sodium(Alendronate Sodium)
Take Alendronate with water only, on an empty stomach at the start of the day. Taking Alendronate with food may decrease the actions of the drug. Take Alendronate at least 30 minutes before any other beverage, food, or other medication for the day. In particular, avoid dairy products and orange juice within 2 hours of this drug. Also avoid laying down for at least 30 minutes after taking this medicine. To avoid irritation to the esophagus (tube connecting mouth to the stomach), this medicine must be taken as directed.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Binosto

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5